The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM
Joined July 2009
- Tweets 14,757
- Following 2,078
- Followers 20,985
- Likes 10,159
5,628 Photos and videos
đź“Ł The IASLC Women in #ThoracicOncology Task Force survey is still open.
If you're a woman working in thoracic oncology, we want to hear about your experiences, perspectives, and priorities. Your feedback will help guide future initiatives to support women across the field.
Take the survey: bit.ly/4uAPNwd
#WomenInMedicine
3
8
752
đź“° Breaking: ILCN editorial board member Dr. @ShirishGadgeel has been appointed to the thoracic oncology team at Winship Cancer Institute. Read more details in ILCN: bit.ly/4uFT8tU
1
3
10
1,039
IASLC retweeted
Great to see the continued strengthening of the partnership between @thoracic and @IASLC at #ESTS2026 in Athens.
Excellent multidisciplinary discussions with @karenkellymd, @paulvanschil and @HaukeWinter at ESTS/IASLC session on global frameworks for AI and perioperative innovation in NSCLC with @FordePatrick.
Thanks Dr Kelly for sharing the @IASLC vision and initiatives with our @ests_womenThor & NextGen community
#IASLC #ESTS2026 #ThoracicSurgery #LungCancer #NSCLC #AI
7
10
1,179
The science. The global community. The conversations that shape what's next. Hear why attendees recommend #WCLC.
⏰ Early Bird registration ends today! Register now and save up to $500 before rates increase.
bit.ly/wclcreg26
#WCLC26 #LungCancer #ThoracicOncology
4
10
2,302
📆 Early Bird registration for #WCLC26 ends tomorrow!
Register by June 12 to save up to $500. IASLC Members can save up to $750 total.
Register now: bit.ly/wclcreg26
5
8
984
IASLC retweeted
Jun 11
In this study, Zanghì et al. used peripheral blood mononuclear cell profiling to personalize LDCT screening intervals to combat false positives and increase accuracy.
đź“‘Read more: bit.ly/3OrV5tR
@IstTumori
1
9
9
1,187
Two days. Global experts. One critical challenge: resistance to #immunotherapy.
Join leading researchers and clinicians in Dublin for IASLC Hot Topic 2026, a highly interactive meeting designed to accelerate discussion, collaboration, and discovery.
Register now: bit.ly/4v8jncA
#LungCancer #ThoracicOncology
4
7
595
🎧 In Part 2 of the #ASCO26 Highlights series, @NarjustFlorezMD and @StephenVLiu are joined by Dr. Julie R. Brahmer and @peters_solange to discuss key immunotherapy advances presented at the 2026 @ASCO Annual Meeting.
The episode covers emerging data on PD-1/VEGF and PD-L1/VEGF bispecific antibodies, ADC-immunotherapy combinations, and promising new strategies for #KRAS-mutant lung cancers.
Listen now : bit.ly/4uZjt6o
#LungCancer #LungCancerConsidered
9
16
1,491
The global #lungcancer community is heading to Seoul for #WCLC26.
Take advantage of Early Bird pricing before June 12 and be part of four days of cutting-edge science, collaboration, and multidisciplinary learning.
Register today: bit.ly/wclcreg26
9
14
1,096
Ready to help shape the future of #WCLC28?
IASLC is accepting applications for 2028 World Conference on Lung Cancer Co-Chairs. Lead scientific discussions, foster global collaboration, and help guide the world's largest thoracic oncology meeting in Copenhagen, Denmark.
Apply today: bit.ly/4oe7a3i
#IASLC #LungCancer #ThoracicOncology
1
6
24
1,930
IASLC retweeted
Jun 5
What has changed most in pulmonary medicine over the last two decades?
An international group of pulmonologists shares their perspective on the evolving role of the specialty in lung cancer care as part of JTO’s 20th Anniversary series.
Read now: bit.ly/4e0oBQk
4
5
960
Have you submitted your abstract yet?
Don't miss the opportunity to present your research at the 2026 #LatinAmerica Conference on #LungCancer and join experts from across the region in advancing thoracic oncology.
Learn more and submit: bit.ly/41Tvnlj
#LungCancer #CancerResearch
1
5
10
1,008
IASLC retweeted
Quite a whirlwind at #ASCO26 with lung cancer updates. For highlights from targeted therapy, Dr. @NarjustFlorezMD and I spoke with Drs. Alice Shaw and Jonathan Goldman for the @IASLC podcast, Lung Cancer Considered. Listen today! #ALK #RET #EGFR
iaslc.org/iaslc-news/lung-ca…
3
22
51
5,402
Planning to attend #WCLC26? Don't miss your chance to save.
Early Bird registration ends June 12.
Join colleagues from around the world in Seoul for groundbreaking science, global collaboration, and hundreds of sessions spanning the full spectrum of thoracic oncology.
Register today: bit.ly/wclcreg26
9
19
5,512
🚨 New in ILCN: Investigational KRAS G12D agents demonstrate promising activity in NSCLC. Learn more: bit.ly/4fLN4v1
#LCSM
5
13
1,663
Have you downloaded IASLC's printable CRS resource yet?
As BiTE therapies continue to emerge in lung cancer treatment, early recognition and management of cytokine release syndrome (CRS) remains critical. This quick guide includes key signs and symptoms, management considerations, and a practical response workflow.
Access the resource: bit.ly/4tzGxXT
Nurses and allied health professionals: Your input can help shape future IASLC education and resources. Take the NAHP survey: bit.ly/48StXvh
#ThoracicOncology #LungCancer #OncologyNursing #CancerCare
1
12
532
🎧 New Lung Cancer Considered episode
In Part 1 of our @ASCO 2026 Highlights series, @NarjustFlorezMD and @StephenVLiu are joined by Dr. Jonathan Goldman and Dr. Alice Shaw to discuss practice-changing data in #NSCLC, including LIBRETTO-432, #ALK-positive disease outcomes, and new #EGFR exon 20 insights. Listen now: bit.ly/4ochDfV
#LungCancer #LungCancerConsidered #ASCO26
15
24
3,801
IASLC retweeted
Jun 4
đź“Š #JTO20 Fun Fact
Each month, JTO Editor’s Choice highlights key articles on topics shaping thoracic oncology.
These selected articles are free to access for 3 months after online publication.
Explore Editor’s Choice at JTO: jto.org/
#LungCancer
2
6
620
What do recent ODAC decisions mean for lung cancer drug development and clinical trial design?
Find out in a new ILCN Q&A with Dr. John V. Heymach.
➡️ bit.ly/4e8qBah
#LCSM
3
5
600
IASLC retweeted
Three weeks to go before the @IASLC 2026 Hot Topic meeting on Resistance to Immunotherapy !
đź“Ť Dublin
🗓️ June 26–27
👉 bit.ly/3NbSROT
Meet the speakers of Session 4 on “Experimental Models and Bioinformatic Approaches to Investigate Resistance”
#HT26 #LCSM
1
5
583